Navigation Links
Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
Date:12/21/2007

- Additional Data Submitted to FDA for Traditional Approval -

YARDLEY, Pa., Dec. 21 /PRNewswire/ -- Tibotec, Inc. today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the protease inhibitor (PI) PREZISTA(TM) (darunavir) tablets, which seeks traditional approval and an expanded indication to include human immunodeficiency virus (HIV)-1-infected, treatment-naive adults. The application includes 48-week data from two Phase 3 studies, ARTEMIS and TITAN, which were presented at HIV conferences earlier this year, as well as 96-week data from the Phase 2b studies, POWER 1, 2, and 3.

PREZISTA received accelerated approval in June 2006 based on the 24-week analysis of HIV viral load and CD4+ cell counts from the pooled analysis of the TMC114-C213 (POWER 1) and TMC114-C202 (POWER 2) Phase 2b studies. As part of the post-marketing commitment, 48-week data from ongoing Phase 3 studies (ARTEMIS and TITAN) and 96-week data from POWER 1, 2, and 3 are required before the FDA can consider traditional approval for PREZISTA.

PREZISTA, co-administered with 100 mg ritonavir and with other antiretroviral agents, is currently indicated for the treatment of human immunodeficiency virus (HIV) infection in antiretroviral treatment-experienced adult patients, such as those with HIV-1 strains resistant to more than one protease inhibitor.

This indication is based on Week 24 analyses of plasma HIV RNA levels and CD4+ cell counts from two controlled trials of PREZISTA/ritonavir (PREZISTA/r) in combination with other antiretroviral drugs. Both studies were conducted in clinically advanced, treatment-experienced (NRTIs, NNRTIs, and PIs) adult patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy.

The following points should be considered when initiating therapy with PREZISTA/r:

-- Treatment history and, when available, genotypic or phenot
'/>"/>

SOURCE Tibotec, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
3. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Indevus Announces Submission of New Drug Application
6. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
7. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
8. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
9. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
10. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
11. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015 /PRNewswire/ -- Concord Medical Services Holdings ... ), a leading specialty hospital management solution provider ... and diagnostic imaging centers in China ... a multi-year strategic development agreement with The University ... an internationally renowned cancer research, treatment and education ...
(Date:5/6/2015)... May 6, 2015 Neuralstem, Inc. (NYSE MKT: ... to develop small molecule and cell therapy treatments for ... Jonathan Lloyd Jones to the position of Chief ... Mr. Lloyd Jones brings to the ... business development experience.   Most recently, Mr. Lloyd Jones ...
(Date:5/6/2015)... First programme to ... rilpivirine   ViiV Healthcare today ... trial programme to evaluate the safety and efficacy ... as maintenance therapy for adult patients with HIV. ... evaluating 48 week viral suppression with a two ...
Breaking Medicine Technology:Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center 2Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center 3Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center 4Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10
... Colo. , June 14 REO, a ... appointed Mark Notarfrancesco to the newly created ... role, Mark will direct all aspects of the company,s ...  Prior to joining REO, Mark served with Intel Corporation ...
... Covance Inc. (NYSE: CVD ) today announced that it will ... Wednesday, June 16, 2010 at 3:00 p.m. (ET) .  Investors may ... to register and download any necessary software, please log on 10 minutes early. ... Covance, with headquarters in Princeton, ...
Cached Medicine Technology:Mark Notarfrancesco Joins REO as VP Manufacturing Operations 2
(Date:5/6/2015)... In celebration of their twentieth anniversary, Premierlacewigs.com ... give away a deluxe human hair lace wig valued at ... enter on a third-party giveaway tool. The important thing is ... the winner. , The hair is a crown, a reflection ... such a jewel for the past 20 years. Whether it ...
(Date:5/6/2015)... May 06, 2015 The American Water ... period for its prestigious Integrated Water Resources Management (IWRM) ... approach to water resources projects. , An IWRM approach to ... establishment in 1964. In 2014, 12 projects were nominated for ... magazine features not only the 2014 AWRA IWRM Award winner ...
(Date:5/6/2015)... NY (PRWEB) May 06, 2015 ... long-standing organization dedicated to activating and celebrating public ... Champion organization, Highmark Health, as an Outstanding Employee ... with the Jefferson Awards Foundation, are dedicated to ... For nearly a decade, Highmark Health has recognized ...
(Date:5/6/2015)... Herndon, VA (PRWEB) May 06, 2015 ... its CIT GAP Funds has invested in e-Kare, Inc. ... speeds the assessment and monitoring of chronic wounds. , ... burn, and complex surgical wounds that affect over 6.5 ... in 2013 as a spin-off enterprise from the Children’s ...
(Date:5/6/2015)... 06, 2015 When it comes to ... more reputable and respected than those of a physician. ... their physician lose more weight than those who received ... conducted by the University of Georgia and published in ... revealed that patients advised by their physicians dropped more ...
Breaking Medicine News(10 mins):Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 2Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 3
... has been detected throughout the Indonesian capital, Jakarta, with the ... on our research, the virus has spread all over the ... of Indonesia's 30 provinces and has killed seven people., ... could be expected, saying that the virus has spread to ...
... Mass Vaccination to children’s against polio virus is conducted ... in Indonesia which has experienced about 290 polio cases ... officials are planning the third round of vaccination program ... mass polio vaccine programs which has provided vaccination to ...
... of the ever-increasing threat about bird flu worldwide, there has ... the drug.// Ranbaxy Laboratories has become the first Indian company ... Tamiflu. The drug is believed to get shipped to a ... would be invalid. ,We have sent small quantities ...
... suspended by the General Medical Council (GMC) of Britain ... a severe infection in a patient who later died.// ... for failing to act when 31-year-old Sean Phillips fell ... Hospital. ,He was convicted of manslaughter and given ...
... research has found that Scotland's kids continue to have the ... the country's overall dental problems found in children aged less ... note of this and has asked parents to start their ... to prevent dental decay. It is generally accepted that decayed ...
... of bird flu infection and some cities are free from ... regions of Dong Thap and An Giang have been tested ... other regions are free from infection which were the main ... free this time due to wide spread vaccination which was ...
Cached Medicine News:Health News:Bird Flu Alarm In Indonesia 2Health News:Scottish Children Have Worst Dental Health In Europe 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: